RX METATYPE Trademark

Trademark Overview

On Wednesday, February 27, 2019, a trademark application was filed for RX METATYPE with the United States Patent and Trademark Office. The USPTO has given the RX METATYPE trademark a serial number of 88318945. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 27, 2021. This trademark is owned by Genomind, Inc.. The RX METATYPE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic testing for medical purposes
rx metatype

General Information

Serial Number88318945
Word MarkRX METATYPE
Filing DateWednesday, February 27, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements

Disclaimer with Predetermined Text"RX"
Goods and ServicesGenetic testing for medical purposes
Pseudo MarkRX META TYPE

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2019
Primary Code044
First Use Anywhere DateWednesday, May 15, 2019
First Use In Commerce DateWednesday, May 15, 2019

Trademark Owner History

Party NameGenomind, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406
Party NameGenomind, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events

Event DateEvent Description
Monday, September 27, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 27, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 15, 2021NON-FINAL ACTION E-MAILED
Monday, March 15, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, February 23, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 3, 2021USE AMENDMENT FILED
Tuesday, February 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 3, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, August 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 3, 2020EXTENSION 1 GRANTED
Monday, August 3, 2020EXTENSION 1 FILED
Monday, August 3, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 4, 2019EXAMINER'S AMENDMENT ENTERED
Monday, November 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2019EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, October 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 31, 2019NON-FINAL ACTION E-MAILED
Thursday, October 31, 2019NON-FINAL ACTION WRITTEN
Thursday, October 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2019ASSIGNED TO LIE
Friday, October 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 4, 2019NON-FINAL ACTION E-MAILED
Thursday, April 4, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 2, 2019ASSIGNED TO EXAMINER
Tuesday, March 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 2, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

metatype purposes medical testing genetic